Quan Vu

Quan brings more than 20 years of “hands-on” healthcare business executive experience with an emphasis on corporate & business development, strategy, finance and operations. He possesses a demonstrated history of closing value-additive business transactions and consummating billions of dollars in capital raises and M&A deals. Before joining Ocugen, he served as Chief Operating Officer/Chief Business Officer for 180 Life Sciences, responsible for the company’s corporate strategy, operational efficiency, communications efforts, business development initiatives, and capital markets access. Prior to 180 Life Sciences, he held leadership roles of increasing responsibility at Opiant Pharmaceuticals, Impax Laboratories, Anthem, and Amgen. Earlier in his career, he worked in the healthcare corporate finance and M&A departments at bulge-bracket investment banks, including Morgan Stanley and Goldman Sachs.

Quan obtained his BA in Economics from UCLA, graduating summa cum laude with College Honors and Economics Departmental Honors. He is also a Certified Treasury Professional (inactive).